Sign Out
Doxorubicin must not be given by the intramuscular or subcutaneous route.
Avoid intraperitoneal prescribing because of danger of intestinal obstruction.
Since intravenous administration may cause vascular pain, phlebitis, thrombus, site of injection and administration method should be cautioned, and administered as possible as slow.
Induration, necrobiosis may occur due to extravasation of the solution in intravenous injection.
Therefore, intravenous administration should be cautioned not to leak the solution.
